Biodefense vaccine enhancement development of a third generation RPA anthrax vaccine
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272200800049C
- Awardee
-
Altimmune, Inc. UEI HCX2XDMYTA35
- Awarding agency
-
NIAID DEA OA Acquisitions
National Institutes of Health, Department of Health and Human Services
- Obligated
- $962,249
Award facts
- Opportunity
-
- BAAAI2007007 Solicitation number
- Biodefense Vaccine Enhancement Award Notice · Posted Sep 6, 2007
- Contract value 100% obligated
- $962,248.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 13 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Cape St Claire, MD 21401, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,937,751 | |
| Other Administrative Action | -$6,100,000 | |
| Other Administrative Action | $0 | |
| Original award | $10,000,000 |
About this award
This is a definitive contract awarded by the National Institutes of Health (NIH) to Altimmune, Inc. for $962,248.52 to support the BIODEFENSE VACCINE ENHANCEMENT program. The contract is a Cost Plus Fixed Fee arrangement with an ultimate completion date of August 6, 2013. Altimmune, Inc. is a for-profit organization that specializes in the development of drugs, biologicals, and vaccines, particularly in the area of biodefense. The contract does not have a set-aside designation. Based on the contract details, Altimmune, Inc. is conducting research and development to enhance existing biodefense vaccines, including the evaluation of clone generation and stability. This work is likely aligned with the NIH's efforts to strengthen the nation's biodefense capabilities.
Quick answers
Who was awarded contract HHSN272200800049C?
HHSN272200800049C was awarded to Altimmune, Inc. by NIAID DEA OA Acquisitions (National Institutes of Health) on September 25, 2008.
How much is contract HHSN272200800049C worth?
The government has obligated $962,249 on HHSN272200800049C.
Was contract HHSN272200800049C competed?
The extent of competition for HHSN272200800049C was full and open competition. The government received 13 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award